Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

CRLF2 over-Expression Is a Poor Prognostic Marker in Children with High Risk T-Cell Acute Lymphoblastic Leukemia

Blood (2014) 124 (21): 1071.

https://doi.org/10.1182/blood.V124.21.1071.1071

Published: 2014

Journal Articles

Outcome of Early T-Cell Precursor Acute Lymphoblastic Leukemia in AIEOP Patients Treated with the AIEOP-BFM ALL 2000 Study

Blood (2014) 124 (21): 3780.

https://doi.org/10.1182/blood.V124.21.3780.3780

Published: 2014

Journal Articles

Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study

Blood (2014) 123 (10): 1470–1478.

https://doi.org/10.1182/blood-2013-10-532598

Published: 2014

Includes: Supplemental data

Journal Articles

Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia

Andrea Pession, Riccardo Masetti, Carmelo Rizzari, Maria Caterina Putti, Fiorina Casale, Franca Fagioli, Matteo Luciani, Luca Lo Nigro, Giuseppe Menna, Concetta Micalizzi, Nicola Santoro, Anna Maria Testi, Marco Zecca, Andrea Biondi, Martina Pigazzi, Sergio Rutella, Roberto Rondelli, Giuseppe Basso, Franco Locatelli

Blood (2013) 122 (2): 170–178.

https://doi.org/10.1182/blood-2013-03-491621

Published: 2013

Journal Articles

Results of the AIEOP AML 2002/01 Study for Treatment of Children with Acute Myeloid Leukemia.

Andrea Pession, C. Rizzari, Maria Caterina Putti, Riccardo Masetti, Fiorina Casale, Franca Fagioli, Luca Lo Nigro, Matteo Luciani, Concetta Micalizzi, Giuseppe Menna, Nicola Santoro, Anna Maria Testi, Roberto Rondelli, Andrea Biondi, Giuseppe Basso, Franco Locatelli

Blood (2009) 114 (22): 17.

https://doi.org/10.1182/blood.V114.22.17.17

Published: 2009

Journal Articles

Detection of CALM-AF10 Fusion Transcript Does Not Predict A Poor Prognosis in Children with T-Lineage Acute Lymphoblastic Leukemia Treated with AIEOP ALL 2000 Protocol and Subsequent Modified 2000 Study (R-2006).

Blood (2009) 114 (22): 1578.

https://doi.org/10.1182/blood.V114.22.1578.1578

Published: 2009

Journal Articles

Prevalence and Prognostic Impact of CEBPA mutations in Children with AML Treated with the AIEOP-LAM 2002/01 Protocol.

Giovanni Cazzaniga, Riccardo Masetti, Giulia Ferrari, Tiziana Coliva, Carmelo Rizzari, Roberto Rondelli, Fiorina Casale, Franca Fagioli, Luca Lo Nigro, Matteo Luciani, Concetta Micalizzi, Giuseppe Menna, Maria Caterina Putti, Nicola Santoro, Giuseppe Basso, Franco Locatelli, Andrea Biondi, Andrea Pession

Blood (2009) 114 (22): 2643.

https://doi.org/10.1182/blood.V114.22.2643.2643

Published: 2009

Journal Articles

Long Term Results of the AIEOP-All-95 Trial for Childhood Acute Lymphoblastic Leukemia. An Insight on the Prognostic Value of Dna Index in the Frame of BFM-Based Chemotherapy.

Maurizio Arico, Maria Grazia Valsecchi, Carmelo Rizzari, Elena Barisone, Andrea Biondi, Fiorina Casale, Franco Locatelli, Luca Lo Nigro, Matteo Luciani, Chiara Messina, Concetta Micalizzi, Rosanna Parasole, Andrea Pession, Nicola Santoro, Anna Maria Testi, Daniela Silvestri, Giuseppe Basso, Giuseppe Masera, Valentino Conter

Blood (2007) 110 (11): 1440.

https://doi.org/10.1182/blood.V110.11.1440.1440

Published: 2007

Journal Articles

TEL/AML1 Rearrangement Is Rare in Children with Acute Lymphoblastic Leukemia (ALL) and Down Syndrome (DS). Presenting Features and Treatment Outcome in the Experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).

Blood (2007) 110 (11): 848.

https://doi.org/10.1182/blood.V110.11.848.848

Published: 2007

Journal Articles

High Dose Methotrexate (HD MTX at 2 gr/sqm x 4) Associated to Extended Intrathecal (IT) Chemotherapy Is Effective for Prevention of Central Nervous System (CNS) Relapse in Childhood ALL Treated with BFM Systemic Therapy.

Blood (2005) 106 (11): 10.

https://doi.org/10.1182/blood.V106.11.10.10

Published: 2005

Journal Articles

Children with TEL/AML1-Positive Acute Lymphoblastic Leukemia (ALL) and Favorable Presenting Features May Benefit from the Use of Vincristine-Dexamethasone (VCR-DXM) Pulses on Top of Antimetabolite-Based Continuation Therapy.

Blood (2005) 106 (11): 9.

https://doi.org/10.1182/blood.V106.11.9.9

Published: 2005

Journal Articles

Dual or Single Hepatitis B and C Virus Infections in Childhood Cancer Survivors: Long-Term Follow-Up and Effect of Interferon Treatment

Riccardo Utili, Rosa Zampino, Pasquale Bellopede, Marta Marracino, Enrico Ragone, Luigi Elio Adinolfi, Giuseppe Ruggiero, Maria Capasso, Paolo Indolfi, Fiorina Casale, Adele Martini, Maria Teresa Di Tullio

Blood (1999) 94 (12): 4046–4052.

https://doi.org/10.1182/blood.V94.12.4046

Published: 1999

NARROW

CRLF2 over-Expression Is a Poor Prognostic Marker in Children with High Risk T-Cell Acute Lymphoblastic Leukemia

Outcome of Early T-Cell Precursor Acute Lymphoblastic Leukemia in AIEOP Patients Treated with the AIEOP-BFM ALL 2000 Study

Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study

Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia

Results of the AIEOP AML 2002/01 Study for Treatment of Children with Acute Myeloid Leukemia.

Detection of CALM-AF10 Fusion Transcript Does Not Predict A Poor Prognosis in Children with T-Lineage Acute Lymphoblastic Leukemia Treated with AIEOP ALL 2000 Protocol and Subsequent Modified 2000 Study (R-2006).

Prevalence and Prognostic Impact of CEBPA mutations in Children with AML Treated with the AIEOP-LAM 2002/01 Protocol.

Long Term Results of the AIEOP-All-95 Trial for Childhood Acute Lymphoblastic Leukemia. An Insight on the Prognostic Value of Dna Index in the Frame of BFM-Based Chemotherapy.

TEL/AML1 Rearrangement Is Rare in Children with Acute Lymphoblastic Leukemia (ALL) and Down Syndrome (DS). Presenting Features and Treatment Outcome in the Experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).

High Dose Methotrexate (HD MTX at 2 gr/sqm x 4) Associated to Extended Intrathecal (IT) Chemotherapy Is Effective for Prevention of Central Nervous System (CNS) Relapse in Childhood ALL Treated with BFM Systemic Therapy.

Children with TEL/AML1-Positive Acute Lymphoblastic Leukemia (ALL) and Favorable Presenting Features May Benefit from the Use of Vincristine-Dexamethasone (VCR-DXM) Pulses on Top of Antimetabolite-Based Continuation Therapy.

Dual or Single Hepatitis B and C Virus Infections in Childhood Cancer Survivors: Long-Term Follow-Up and Effect of Interferon Treatment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only